Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(20%)
Results Posted
33%(1 trials)
Terminated
1(20%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
75.0%

Trials by Status

completed360%
active_not_recruiting120%
terminated120%

Recent Activity

1 active trials
Showing 5 of 5
completed

LVAD Index and Clinical Outcomes in Continuous-Flow LVAD Patients

NCT07633535
active_not_recruiting

Destination Therapy Post Approval Study

NCT03681210
completed

Apogee, A HeartWare HVAD Destination Product Surveillance Registry (PSR) Platform

NCT03697980
terminated

Apogee International

NCT04065997
completed

Mechanical Circulatory Support Korea Post Market Surveillance Study (PMS)

NCT04543747

Clinical Trials (5)

Showing 5 of 5 trials
NCT07633535

LVAD Index and Clinical Outcomes in Continuous-Flow LVAD Patients

Completed
NCT03681210

Destination Therapy Post Approval Study

Active Not Recruiting
NCT03697980

Apogee, A HeartWare HVAD Destination Product Surveillance Registry (PSR) Platform

Completed
NCT04065997

Apogee International

Terminated
NCT04543747

Mechanical Circulatory Support Korea Post Market Surveillance Study (PMS)

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5